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nsD3 keeps iRF3 active
In this issue of JEM, Wang et al. (https ://doi .org /10 .1084 /jem .20170856) show a novel antiviral innate mechanism by which 
methyltransferase NSD3 directly monomethylates a transcription factor IRF3 and maintains IRF3 phosphorylation to enhance 
its transcriptional activity, consequently promoting antiviral innate immune responses.
Antiviral innate immune responses are a 
critical first line of host defense against in-
vading viral pathogens (Akira et al., 2006; 
Takeuchi and Akira, 2010; Moresco et al., 
2011). Viral RNA and DNA is initially 
recognized by pattern recognition recep-
tors (PRRs) such as TLRs, retinoic acid–
inducible gene-I (RIG-I)–like receptors 
(RLRs), Nod-like receptors (NLRs), and 
cyclic GMP-AMP (cGAMP) synthase 
(cGAS). TLRs are transmembrane pro-
teins recognizing microbial components 
on the cell surface or in the endosomes. 
Among the TLRs expressed on the en-
dosome, TLR3, TLR7, and TLR9 sense 
viral double-stranded RNA (dsRNA), 
single-stranded RNA (ssRNA), and 
DNA with a CpG motif, respectively. 
In addition to TLRs, cytoplasmic RLRs, 
RIG-I and melanoma differentiation-as-
sociated gene 5 (MDA5) recognize 5′-tri-
phosphate end dsRNA and long dsRNA, 
respectively (Yoneyama and Fujita, 2009). 
Cytosolic DNA sensor, cGAS, senses viral 
DNAs (Barrat et al., 2016). Extensive 
studies have revealed that the PRR sig-
naling pathways lead to transcription of 
type I IFNs via transcription factors, in-
cluding IFN-regulatory factor 3 (IRF3) 
and IRF7 (Honda et al., 2006). PRR sig-
naling also activates another transcription 
factor, NF-κB, which contributes to the 
transactivation of proinflammatory cyto-
kines as well as type I IFNs.
IRF3 and IRF7 are key transcrip-
tion factors responsible for induction of 
type I IFNs by viral infection and play a 
critical role in host antiviral innate im-
munity (Banchereau and Pascual, 2006; 
Honda et al., 2006; Sadler and Williams, 
2008). IRF3 is constitutively expressed 
and resides in the cytosol in its latent 
form. Posttranslational modifications 
(PTMs), including phosphorylation and 
polyubiquitination, are key features of 
signal transduction pathways that allow 
the modulation of protein function 
(Deribe et al., 2010; Mowen and David, 
2014; Liu et al., 2016). Upon viral in-
fection, PTMs can affect the activation 
of signaling molecules, as well as their 
cellular translocation, stabilization, or 
interaction with other molecules. In-
deed, IRF3 undergoes phosphorylation 
by TBK1 and IKKε after the PRR sig-
naling, which induces IRF3 dimeriza-
tion and nuclear translocation, resulting 
in transcription of type I IFN mRNA 
(Fitzgerald et al., 2003; Takeuchi and 
Akira, 2009). In addition, unconven-
tional PTMs, including methylation, 
acetylation, sumoylation, and succinyla-
tion, have also been implicated in the 
regulation of innate immune system 
(Mowen and David, 2014). However, 
the role of IRF3 methylation in antiviral 
responses has not been understood.
In this issue of JEM, Wang et al. 
demonstrate that monomethylation of 
IRF3 at lysine 366 (K366) is induced 
by infection with herpes simplex virus 
(HSV) and vesicular stomatitis virus 
(VSV). Methylation-defective substitu-
tion at K366 (K366A) significantly abol-
ished IRF3-driven Ifnb activation and 
IFN-β production upon VSV infection. 
These data suggest that viral infection 
induces monomethylation of IRF3 at 
K366, which is responsible for promoting 
IRF3 activation and IFN-β production.
To identify methyltransferases me-
diating the K366-monomethylation of 
IRF3, the Wang et al. (2017) performed 
coimmunoprecipitation and mass spec-
trometry analysis. They found that a ly-
sine methyltransferase, NSD3, directly 
binds to IRF3. The K366 methylation of 
IRF3 was inhibited by VSV infection in 
infected NSD3-deficient macrophages. 
Moreover, an in vitro methylation assay 
showed that NSD3 directly methylates 
IRF3. NSD3-deficient mice were more 
susceptible to VSV infection and showed 
a decreased level of IFN-β production 
in serum and organs, as well as increased 
VSV replication and titers in organs 
compared with control mice. These re-
sults show that NSD3 directly methyl-
ates IRF3 at K366 upon viral infection, 
and NSD3 is an essential methyltrans-
ferase for the production of type I IFN 
and antiviral innate responses. Although 
the authors demonstrated that NSD3 
interacts with the IRF3 C-terminal re-
gion through its PWWP1 domain and 
that the NSD3-mediated IRF3 methyl-
ation occurs in the nucleus, it is not yet 
clear how NSD3 specifically methylates 
IRF3 at K366 upon viral infection. It is 
interesting to speculate that the activity 
of NSD3 to methylate IRF3 is also dy-
namically controlled by viral infection.
Wang et al. (2017) subsequently 
investigated mechanisms of how the 
NSD3-mediated IRF3 methylation 
regulates IRF3 activity. Interestingly, 
VSV-induced IRF3 phosphorylation at 
Ser388 requires NSD3, and NSD3-me-
diated IRF3 methylation suppressed the 
interaction of IRF3 with protein phos-
phatase 1 (PP1), which is involved in 
the regulation of IRF3 activity via de-
phosphorylation (Gu et al., 2014). These 
data demonstrate that NSD3 decreases 
the binding of PP1 to IRF3, preventing 
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dephosphorylation of IRF3 by PP1 and 
consequently resulting in maintenance 
of IRF3 phosphorylation and IFN-β 
production (see figure). However, it is 
unclear how the NSD3-mediated IRF3 
methylation blocks the binding of PP1 to 
IRF3. Because the PP1-binding domain 
of IRF3 does not overlap with the K366 
site and the IRF3 methylation does not 
have a direct effect on the binding of PP1 
to IRF3, it is interesting to speculate that 
potential proteins associating with meth-
ylated IRF3 block the binding of PP1 
to IRF3. It will be interesting to inves-
tigate whether IRF7 methylation is also 
important for antiviral innate responses 
because IRF7 is also key transcription 
factor responsible for induction of type I 
IFNs by viral infection.
In summary, this study provides 
a novel layer of IRF3 regulation via 
NSD3-mediated regulation controlling 
IRF3 activity in response to viral in-
fection. PP1-mediated dephosphor-
ylation functions as a fail-safe system 
of the IRF3 activation, and NSD3-in-
duced methylation seems to remove the 
safety device of type I IFN production. 
Given that dysregulated production of 
type IFNs is the cause of type I inter-
feronopathy, NSD3 in addition to TBK1 
and IKKε appear to be required for tight 
control of innate immunity (Crow and 
Manel, 2015). Antiviral immunoreac-
tivity might potently be manipulated 
by controlling NSD3 activity by using 
an activator or inhibitor of NSD3 via 
IRF3-mediated IFN production. Fu-
ture studies may further characterize the 
mechanisms and importance of PTMs 
in antiviral immune responses.
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NSD3 maintains IRF3 phosphorylation to enhance its transcriptional activity, promoting antiviral 
innate immune response. Transcription factor IRF3 is phosphorylated upon viral infection, and 
the phosphorylated IRF3 undergoes dimerization and nuclear translocation. In the nucleus, 
methyltransferase NSD3 directly methylates IRF3 at K366, and the NSD3-mediated IRF3 
methylation maintains phosphorylation of IRF3 by preventing IRF3 dephosphorylation via 
disrupting the association of PP1 with IRF3.
